<DOC>
	<DOCNO>NCT00747123</DOCNO>
	<brief_summary>Multi-center , randomize , multiple-dose study evaluate safety , tolerability efficacy ACE-011 patient osteolytic lesion multiple myeloma .</brief_summary>
	<brief_title>A Safety , Tolerability Efficacy Study ACE-011 Patients With Osteolytic Lesions Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Key Patient least 18 year age stage II III multiple myeloma One lytic bone lesion If currently receive bisphosphonate therapy , stable dose ≥ 2 month dose day 1 must receive bisphosphonates within 2 month dose day 1 If patient undergone previous autologous allogenic hematopoietic stem cell transplantation ( HSCT ) , must stable ( opinion investigator ) minimum 6 month since HSCT Has plan HSCT duration study Has mole lesion currently undiagnosed , suspect malignancy Has underlying condition may result abnormal bone metabolism cancer relate bone lesion , history hyperparathyroidism , hypoparathyroidism , hypocalcemia , rheumatoid arthritis , myeloproliferative disorder , gout , Paget 's disease bone , osteomalacia ; patient diagnosis osteoporosis prior multiple myeloma diagnosis eligible participate . Key Known underlie condition may result abnormal bone metabolism cancer relate bone lesion History polyneuropathy ≥ grade 3 Patients plasma cell leukemia Planned stem cell transplant ( HSCT ) radiation duration study Skeletal relate event within 2 week study enrollment Has receive erythropoiesisstimulating agent ( ESAs ) within last 21 day plan receive ESAs course study Has receive antimyeloma therapy within last 21 day Is schedule receive local radiation bone course study Has take estrogen , androgen , anabolic steroid , calcitonin boneactive drug within 4 month study enrollment Woman childbearing potential ( undergone hysterectomy postmenopausal least 24 consecutive month )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>